“Increasing Adoption of Drug-Eluting and Bioengineered Vascular Grafts”
- There is a growing trend toward the use of drug-eluting vascular grafts and stents, which help reduce restenosis by releasing medication directly into the vessel walls.
- Bioengineered vascular grafts made from tissue-engineered materials are gaining traction due to their improved compatibility and reduced risk of rejection compared to synthetic options.
- These advanced grafts support faster healing and lower the need for repeat interventions, thus improving patient outcomes and reducing healthcare costs.
- For instance, companies such as Terumo and Gore Medical have developed drug-eluting stents that are widely adopted for peripheral artery disease treatments, enhancing efficacy.
- For instance, use of tissue-engineered grafts by Cytograft Tissue Engineering, which offer promising alternatives for bypass surgeries and show potential to transform vascular surgery standards.
- For instance, companies such as Terumo and Gore Medical have developed drug-eluting stents that are widely adopted for peripheral artery disease treatments, enhancing efficacy.
